Background & Aims: Early detection and treatment of esophageal cancer
in Barrett's esophagus may improve patient survival if dysplasia is ef
fectively detected at endoscopy. Typically, four-quadrant pinch biopsy
specimens are taken at 2-cm intervals. This study was conducted to de
termine whether laser-induced florescence spectroscopy could be used t
o detect high-grade dysplasia in patients with Barrett's esophagus. Me
thods: Four hundred ten-naonometer laser light was used to induce auto
fluorescence of Barrett's mucosa in 36 patients. The spectra were anal
yzed using the differential normalized fluorescence (DNF) index techni
que to differentiate high-grade dysplasia from either low-grade or non
dysplastic mucosa. Each spectrum was classified as either premalignant
or benign using two different DNF indices. Results: Analysis of the f
luorescence spectra from all patients collectively using the DNF inten
sity at 480 nm (DNF480) index showed that 96% of nondysplastic Barrett
's esophagus samples were classified as benign, all low-grade dysplasi
a samples as benign, 90% of high-grade dysplasia samples as premaligna
nt, and 28% of low-grade with focal high-grade dysplasia samples as pr
emalignant. Using the two DNF indices concurrently, all patients with
any high-grade dysplasia were classified correctly. Conclusions: Laser
-induced fluorescence spectroscopy has great potential to detect high-
grade dysplasia in Barrett's esophagus when using the DNF technique.